Kyverna Therapeutics, Inc.
KYTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$37 | -$42 | -$45 | -$37 |
| Dep. & Amort. | $0 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3 | $2 | $0 |
| Change in WC | -$9 | $8 | -$2 | $0 |
| Other Non-Cash | $2 | -$1 | -$1 | -$0 |
| Operating Cash Flow | -$43 | -$32 | -$45 | -$37 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | $0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$73 | -$95 | -$81 | -$127 |
| Inv. Sales/Matur. | $96 | $124 | $85 | $157 |
| Other Inv. Act. | $0 | -$0 | $2 | $0 |
| Investing Cash Flow | $23 | $29 | $6 | $29 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | -$0 | -$0 |
| Stock Issued | $2 | -$0 | -$0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | $0 | $0 |
| Financing Cash Flow | $1 | -$1 | -$0 | -$0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$19 | -$3 | -$40 | -$8 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $53 | $57 | $97 | $105 |
| End Cash | $34 | $54 | $57 | $97 |
| Free Cash Flow | -$44 | -$32 | -$45 | -$38 |